$80.01
+0.84 (+1.06%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+26.78%
1Y
+139.55%
YTD
+29.61%
Open$78.99
Previous Close$79.17
Day High$80.40
Day Low$78.27
52W High$80.20
52W Low$31.99
Volume—
Avg Volume2.25M
Market Cap9.80B
P/E Ratio—
EPS$-6.84
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$63.59
Above
SMA 200
$49.97
Above
RSI (14)
55.5
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
28 analysts
Price Target
-0.2% upside
Current
$80.01
$80.01
Target
$79.81
$79.81
$53.35
$79.81 avg
$115.71
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 91.21M | 93.42M | 617.31M |
| Net Income | -813,253,876 | -749,696,290 | 113.32M |
| Profit Margin | -891.6% | -847.0% | 18.4% |
| EBITDA | -749,457,303 | -729,268,091 | 314.99M |
| Free Cash Flow | — | — | 143.60M |
| Rev Growth | -2.4% | -2.4% | +3.9% |
| Debt/Equity | 0.59 | 0.59 | 0.20 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.76 | +2.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $347.01 | +0.66% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.05 | +0.14% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $468.42 | +0.35% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $618.03 | +0.90% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $288.18 | +0.62% | 64.3 | 37.13B |